The Effect of Cerebral White Matter Lesions on Walking Time & Vascular Risk Factors

Year 2024, , 191 - 198, 14.06.2024

Miray Erdem , Derya Ozdogru , Aygül Tantik Pak , Elif Banu Söker , Zülfikar Arlıer

https://doi.org/10.5798/dicletip.1501114

Abstract

Introduction: White matter lesions are common neurological diseases in the elderly. In this study, we aimed to investigate the impact of cerebral white matter lesions on walking time and daily living activities in the elderly population.
Methods: A total of 82 individuals, including 40 healthy volunteers and 42 age and sex-matched patients, were enrolled in this study. Magnetic resonance imaging findings were recorded based on the Fazekas Staging System. Risk factors potentially predisposing individuals to white matter lesions were documented through laboratory testing. Additionally, atherothrombotic plaque formations and stenosis were graded using Carotid and Vertebral Artery Doppler Ultrasonography in patients with white matter lesions. The Lawton Instrumental Activities of Daily Living Scale, Mini-Mental State Examination, and the Timed Up & Go Test were administered to both the patient and control groups to assess daily living activities and cognitive functions.
Results: The results of this research showed that as the percentage of stenosis increased in Carotid and Vertebral Artery Doppler Ultrasonography, there were corresponding decreases in Lawton Instrumental Activities of Daily Living Scale scores, haemoglobin and hematocrit values while fasting blood glucose and homocysteine levels increased as expected. Furthermore, significant differences were observed in the Timed Up & Go Test in advanced stages when evaluated according to the Fazekas Staging System.
Conclusion: Our study indicated that white matter lesions do not significantly affect daily living activities but prolong the walking time in elderly individuals.

Keywords

White Matter, Magnetic Resonance Imaging, Walking, Stroke, Brain, Gait

References

• 1.Shindo A, Ishikawa H, Ii Y, et al. Clinical Features andExperimental Models of Cerebral Small Vessel Disease.Front Aging Neurosci. 2020; 12:109.
• 2.Shi Y, Wardlaw JM. Update on cerebral small vesseldisease: a dynamic whole-brain disease. Stroke VascNeurol. 2016;1(3):83-92.
• 3.Sonohara K, Kozaki K, Akishita M, et al.White matterlesions as a feature of cognitive impairment, low vitality and other symptoms of geriatric syndrome in the elderly. Geriatr Gerontol Int. 2008;8(2):93-100.
• 4.Öztürk İ, Tantik Pak A, Şengül HS, et al. The effect oncognitive functions of vascular lesion localizations andvascular load in the brain. Turkish Journal ofCerebrovascular Diseases 2021; 27(2): 133-8.
• 5.Zhang X, Li J, Zeng JJ. The association between whitematter lesions and carotid plaque score: aretrospective study based on real-world populations.Eur Rev Med Pharmacol Sci. 2022;26(24):9365-71.
• 6.White Matter Lesions: NCBI Bookshelf. A service ofthe National Library of Medicine, National Institutes ofHealth. Treasure Island (FL): StatPearls Publishing;2021. Available from: https://www.researchgate.net/publication/353372481. Accessed: 2021 Jan-Bookshelf ID: NBK562167. LastUpdate: September 13, 2021.
• 7.Rost NS, Brodtmann A, Pase MP, et al. Post-StrokeCognitive Impairment and Dementia. Circ Res.2022;130(8):1252-71.
• 8.Guo Q, He Y, Liu X, et al. Features of hyperintensewhite matter lesions and clinical relevance. Chin Med J.2022;135(8):962-70.
• 9.Sinani O, Dadouli K, Ntellas P, et al. Associationbetween white matter lesions and Parkinson's disease: an impact on Postural/Gait difficulty phenotype andcognitive performance. Neurol Res.2022;44(12):1122-31.
• 10.Egorova-Brumley N, Liang C, Khlif MS, et al. Whitematter microstructure and verbal fluency. Brain StructFunct. 2022;227(9):3017-25.
• 11.Grey MT, Mitterová K, Gajdoš M, et al. Differentialspatial distribution of white matter lesions inParkinson's and Alzheimer's diseases and cognitivesequelae. J Neural Transm (Vienna). 2022Aug;129(8):1023-30.
• 12.Tuladhar AM, van Norden AG, de Laat KF, et al.White matter integrity in small vessel disease is related to cognition. NeuroImage Clinical. 2015; 7:518-24.
• 13.Baldassarro VA, Stanzani A, Giardino L, et al.Neuroprotection and neuroregeneration: roles for thewhite matter. Neural Regen Res. 2022; 17(11):2376-80.
• 14.Hu AM, Ma YL, Li YX, et al. Association betweenChanges in White Matter Microstructure and Cognitive Impairment in White Matter Lesions. Brain Sci. 2022;12(4):482.
• 15.Bonkhoff AK, Hong S, Bretzner M, et al. Associationof Stroke Lesion Pattern and White MatterHyperintensity Burden With Stroke Severity andOutcome. Neurology. 2022 Sep 27; 99(13): e1364-e1379.
• 16.Yasuda K, Ayaki T, Li F, et al. White matteredematous change with moderate vascular lesions inpretreated acute stage of leukoencephalopathy withcerebral amyloid angiopathy. Neuropathology. 2022;42(2):134-140.
• 17.Cha S, Jeong B, Choi M et al. White matter tractsinvolved in subcortical unilateral spatial neglect insubacute stroke. Front Neurol. 2022; 13:992107.
• 18.Dadar M, Mahmoud S, Narayanan S, et al. Diffuselyabnormal white matter converts to T2 lesion volume in the absence of MRI- detectable acute inflammation.Brain. 2022;145(6):2008-2017.